Grace Therapeutics, Inc
NASDAQ:GRCE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Grace Therapeutics, Inc
NASDAQ:GRCE
|
US |
|
H
|
Hsinjing Holding Co Ltd
TPEX:3713
|
TW |
|
K
|
Karam Ceramics Ltd
KAR:KCL
|
PK |
|
H
|
Highnoon Laboratories Ltd
KAR:HINOON
|
PK |
|
B
|
BBD Initiative Inc
TSE:5259
|
JP |
Wall St Price Targets
GRCE Price Targets Summary
Grace Therapeutics, Inc
According to Wall Street analysts, the average 1-year price target for
GRCE is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GRCE's stock price target?
Price Target
6.12
USD
According to Wall Street analysts, the average 1-year price target for
GRCE is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.